scispace - formally typeset
Open AccessJournal ArticleDOI

Novel anticancer therapeutics targeting telomerase.

Maria Ruden, +1 more
- 01 Aug 2013 - 
- Vol. 39, Iss: 5, pp 444-456
Reads0
Chats0
TLDR
The most promising current telomerase targeting therapeutics are the antisense oligonucleotide inhibitor GRN163L and immunotherapies that use dendritic cells (GRVAC1), hTERT peptide (GV1001) or cryptic peptides (Vx-001).
About
This article is published in Cancer Treatment Reviews.The article was published on 2013-08-01 and is currently open access. It has received 307 citations till now. The article focuses on the topics: Telomerase reverse transcriptase & Telomerase.

read more

Citations
More filters
Journal ArticleDOI

Comprehensive and Integrative Genomic Characterization of Hepatocellular Carcinoma

Adrian Ally, +235 more
- 15 Jun 2017 - 
TL;DR: Integrative molecular HCC subtyping incorporating unsupervised clustering of five data platforms identified three subtypes, one of which was associated with poorer prognosis in three HCC cohorts and development of a p53 target gene expression signature correlating with poor survival was enabled.
Journal ArticleDOI

Roles of telomeres and telomerase in cancer, and advances in telomerase-targeted therapies

TL;DR: Key aspects of telomerase assembly, intracellular trafficking and recruitment to telomeres for completing DNA synthesis, which may provide novel targets for the development of anticancer agents are revealed.
Journal ArticleDOI

Coumarins as anticancer agents: A review on synthetic strategies, mechanism of action and SAR studies

TL;DR: This is the first standalone review that emphasis on the assorted retrosynthetic approaches, important targets for molecularly targeted cancer therapy and structure activity relationship studies that highlight the chemical groups responsible for evoking the anticancer potential of coumarin derivatives reported from 2011 to 2014.
Journal ArticleDOI

Upregulating mutations in the TERT promoter commonly occur in adult malignant gliomas and are strongly associated with total 1p19q loss

TL;DR: The data indicate that mutation of the TERT promoter is one of the major mechanisms of telomerase activation in gliomas, and suggests that they play distinct roles in the pathogenesis of oligodendroglial and astrocytic tumors.
References
More filters
Journal ArticleDOI

TRF2 Protects Human Telomeres from End-to-End Fusions

TL;DR: It is shown that the human telomeric protein TRF2 plays a key role in the protective activity of telomeres, and the results raise the possibility that chromosome end fusions and senescence in primary human cells may be caused by loss byTRF2 from shortenedtelomeres.
Journal ArticleDOI

Tankyrase, a Poly(ADP-Ribose) Polymerase at Human Telomeres

TL;DR: Tankyrase, a protein with homology to ankyrins and to the catalytic domain of poly(adenosine diphosphate-ribose) polymerase (PARP), was identified and localized to human telomeres.
Journal ArticleDOI

Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging.

TL;DR: Telomeres and telomerase: the path from maize, Tetrahymena and yeast to human cancer and aging is traced.
Journal ArticleDOI

Telomeres and telomerase in cancer.

TL;DR: The role of telomeres and telomerase is covered in the biology of normal tissue stem/progenitor cells and in the development of cancer to uncover the underlying mechanisms driving genome instability in cancer.
Journal ArticleDOI

Telomerase and cancer therapeutics

TL;DR: The prospect of adding telomerase-based therapies to the growing list of new anticancer products is promising, but what are the advantages and limitations of different approaches, and which patients are the most likely to respond?
Related Papers (5)